FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus FDAgov

The FDA converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval.

FDA approved a new drug to treat S. aureus bloodstream infections; acute bacterial skin & skin structure infections; and community-acquired bacterial pneumonia.

The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant…